![Sachiyo Minegishi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sachiyo Minegishi
Geschäftsführer bei
Rectify Pharmaceuticals LLC
Profil
Sachiyo Minegishi is currently Chief Operating Officer at Rectify Pharmaceuticals LLC since 2023.
Former positions include Independent Director at Mural Oncology Plc from 2024 to 2025, Vice President at bluebird bio, Inc. from 2016 to 2020, Senior Director-US Cardiology Rare Disease at Aegerion Pharmaceuticals, Inc. from 2012 to 2016, and Chief Financial Officer at Akouos, Inc. Education includes an undergraduate degree from Massachusetts Institute of Technology and an MBA from The Wharton School of the University of Pennsylvania.
Aktive Positionen von Sachiyo Minegishi
| Unternehmen | Position | Beginn |
|---|---|---|
Rectify Pharmaceuticals LLC
 Rectify Pharmaceuticals LLC BiotechnologyHealth Technology Operates as a biotechnology company that develops positive functional modulators | Geschäftsführer | 01.04.2023 |
Ehemalige bekannte Positionen von Sachiyo Minegishi
| Unternehmen | Position | Ende |
|---|---|---|
| GENETIX BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01.09.2020 |
| AEGERION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.04.2016 |
| AKOUOS | Finanzdirektor/CFO | - |
Ausbildung von Sachiyo Minegishi
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
67
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akouos, Inc.
 Akouos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a genetic medicine company that develops adeno-associated viral vector-based gene therapies for sensorineural hearing loss | Commercial Services |
Rectify Pharmaceuticals LLC
Rectify Pharmaceuticals LLC BiotechnologyHealth Technology Operates as a biotechnology company that develops positive functional modulators | Health Technology |
